Navigation Links
Creating a Road Map for Successful Metabolic New Product Launches
Date:4/8/2011

CHAPEL HILL, N.C., April 8, 2011 /PRNewswire/ -- Recent biopharmaceutical product launches have produced both noteworthy failures and successes, especially in the metabolic therapeutic area. Faced with a continually evolving launch landscape, organizations are rethinking the factors that play the biggest role in the current launch environment.

In a new wide-ranging research project that explores the pivotal success factors and failure points facing new product launches, Best Practices, LLC established a critical core set of factors that can make or break a market entry for metabolic products as well as other types of therapies.

The report, Success Factors and Failure Points in Metabolic Product Launches, examines key launch issues and offers launch leaders two perspectives: a metabolic/diabetes segment and a total benchmark class segment. The study presents a framework for launch success:  the ability to differentiate, a defined target patient population, investment in launch activities, engagement of thought leaders, education of key stakeholders, demonstration of value, utilization of new technologies and avoidance of launch pitfalls.

In addition to delivering qualitative and quantitative insights on each aspect of this launch framework, the 182-page report presents launch leaders' perspectives on the current and future risk levels for an array of pitfall factors that can affect a launch.

To download a complimentary study excerpt, go to: http://www3.best-in-class.com/rr1056.htm.

Best Practices, LLC used both field surveys and interviews to complete this study. In all, 44 managers and executives at 38 leading bio-pharma companies participated in the survey.  In-depth interviews were conducted with leaders from six organizations who have decades of experience with pharma launches.

Topics covered in
'/>"/>

SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. CMS Admits New Surety Bond and Accreditation Requirement for Home Medical Equipment Suppliers Creating Patient Access Issues
2. Sanofi-aventis to Acquire Chattem Inc., Creating a Strong U.S. Consumer Healthcare Platform
3. Creating Healthcare Reform from the Inside Out Through Supply Chain Best Practices that Improve Financial and Clinical Performance is Focus of 2010 GHX Supply Chain Summit
4. Learn How Merck is Creating a Unified Culture and Company Brand During NewsGator Webinar Entitled: From MyMerck to OneMerck - Enterprise 2.0
5. Empire BlueCross BlueShield Expands Lab Networks -- Creating Broader Choice, Robust Competition and Lower Costs for Consumers
6. Graymark Healthcare Agrees to Sell Pharmacy Division to Walgreens Creating Pure Play Sleep Apnea Company
7. Medco Completes Acquisition of United BioSource Corporation, Creating Powerful Engine for Rapidly Advancing Clinical Insight and Innovation
8. Creating Partnerships Across R&D and Marketing to Ensure a Successful Global Launch
9. Sanofi-aventis to Acquire BMP Sunstone Creating a Strong Consumer Healthcare Platform in China
10. Creating a Platform for Managed Care Pull-Through Success in 2011
11. Creating an Effective Regulatory Affairs Group for NDA Interactions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... , July 7, 2015 ... of drugs within human and veterinary oncology, has filed ... and Exchange Commission, in connection with the proposed public ... Stock Market. The number of American Depositary Shares, representing ... for the offering have not yet been determined. An ...
(Date:7/7/2015)...  Monopar Therapeutics LLC, an emerging biopharmaceutical company focusing ... and CEO, Chandler D. Robinson MD, MBA, ... Award. The British Council selected one recipient from each ... , and the United States ... who have leveraged their U.K. education in their subsequent ...
(Date:7/7/2015)...   Abide Therapeutics , a developer of ... dosing of the first subject in a Phase ... endocannabinoid system modulator. ABX-1431 was discovered with Abide,s ... drug candidates that target serine hydrolases, a large ... human physiology and disease. "This is ...
Breaking Medicine Technology:Oasmia Pharmaceutical Files a Registration Statement on Form F-1/A for its Proposed Public Offering and an Application with NASDAQ for a US Listing and Announces Investor Roadshow 2Monopar Therapeutics Announces Founder And CEO Chandler Robinson Awarded The British Council's Education U.K. Alumni Award 2Monopar Therapeutics Announces Founder And CEO Chandler Robinson Awarded The British Council's Education U.K. Alumni Award 3Abide Therapeutics Announces First Subject Dosed in First-in-Human Clinical Study of ABX-1431, an Investigational Endocannabinoid System Modulator 2Abide Therapeutics Announces First Subject Dosed in First-in-Human Clinical Study of ABX-1431, an Investigational Endocannabinoid System Modulator 3
... 2011 Thoratec Corporation (NASDAQ: THOR ), ... to save, support and restore failing hearts, announced today ... of an additional $50 million of the company,s shares ... authorization, the total amount available for share repurchases by ...
... University of California San Diego Extension Certificate Program in ... seminar from 5 to 7 pm Thursday, December 8 ... The seminar on conducting clinical trials in Latin America, ... but advance registration is required. The certificate ...
Cached Medicine Technology:Thoratec Corporation Authorizes Additional $50 Million Share Repurchase Program 2Thoratec Corporation Authorizes Additional $50 Million Share Repurchase Program 3UC San Diego Clinical Trials for Latin America International Seminar at Hospital Angeles in Tijuana 2UC San Diego Clinical Trials for Latin America International Seminar at Hospital Angeles in Tijuana 3
(Date:7/7/2015)... Michigan (PRWEB) , ... July 07, 2015 , ... ... the heart of Downtown Detroit was the site of the National Baptist Convention ... Wellness Initiative. Focusing on encouraging and promoting the collaboration of churches and their ...
(Date:7/7/2015)... ... July 07, 2015 , ... Dr. Poneh Ghasri , cosmetic dentist in ... teeth whitening is one of the fastest, easiest ways to brighten a smile. Stained ... smile satisfaction and confidence. With the right teeth whitening treatment, patients can restore a ...
(Date:7/7/2015)... ... July 07, 2015 , ... Office Practicum ... company’s new Chief Financial Officer, effective July 6th, 2015. Ellen joins Office Practicum ... from a multi-billion dollar, global chemical company to early and growth-stage technology companies. ...
(Date:7/7/2015)... IL (PRWEB) , ... July ... ... Inc., a leading provider of unified communication management solutions, has announced the ... Infortel® Select. , This service pack includes a number of enhancements to ...
(Date:7/7/2015)... ... ... an onsite job fair to hire 400 people for its new site in Memphis. The ... 8, and Thursday, July 9, from 9:00 a.m. – 5:00 p.m. , During the two ... onsite interviews. Interested parties are encouraged to attend the job fair or go to ...
Breaking Medicine News(10 mins):Health News:A Forever Recovery CEO Per Wickstrom Speaks to Audience at National Baptist Convention's 11th Annual Health Fair 2Health News:A Forever Recovery CEO Per Wickstrom Speaks to Audience at National Baptist Convention's 11th Annual Health Fair 3Health News:Los Angeles Cosmetic Dentist, Poneh Ghasri DDS, Now Offers Promotions on Whitening Treatments 2Health News:Los Angeles Cosmetic Dentist, Poneh Ghasri DDS, Now Offers Promotions on Whitening Treatments 3Health News:Office Practicum Announces new CFO 2Health News:ISI Telemanagement Solutions, Inc. Releases Service Pack 5600 for Infortel® Select 2Health News:Connexion Point, a tech enabled healthcare services company, is holding on-site job fair July 8th and 9th to fill 400 positions at its new Memphis location 2
... just approved for treating leukemia, also shows promise against a ... approved the use of a promising anti-leukemia drug for treatment ... Gleevec, administered as a pill once a day, is effective ... to target and kill cancer cells without attacking healthy cells ...
... study on a vaccine made from the immune system ... a promising. Dr. Johannes Vieweg, associate professor of urology ... Medical Center in Durham, tested the vaccine on 13 ... uses the men's own dendritic cells, extracted white blood ...
... is derived from a leafy plant native to the South ... in approximately 25 cases of liver diseases. The herb is ... treat insomnia, anxiety, stress and muscle spasms. According to experts, ... benzodiazepines but is not chemically related. ,Benzodiazepines have been ...
... Scientists claim that just by looking at a person's face ... actuality is that smokers age faster than non smokers.A study ... the genes responsible for a skin enzyme that breaks down ... protein of the skin and maintains the elasticity of the ...
... fertility found that women who experienced pleasurable sex retained more ... The best way to get pregnant is to have a ... Cathy, from the School of Psychology at Ohio University, studied ... were asked to go to a clinic within a few ...
... putting its best foot forward in completing its ... company promote Zyban, its anti-smoking drug. Glaxo is ... of its policy, along with providing teams to ... of the corporate, which have negotiated for this ...
Cached Medicine News:
Picofluor™ Fluorometer is a lightweight, inexpensive, handheld fluorometer, configured for the fluorescent probes commonly used for nucleic acid and protein quantitation....
... FLUORAT®-02-PANORAMA spectrofluorometer ... sophisticated instrument among ... It is intended ... chromatographic analysis, and ...
Inquire...
Inquire...
Medicine Products: